Axiom Investors’s CareDx CDNA Stock Holding History

Axiom Investors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,370	Closed	-$822K	–	120
2019 Q3	$822K	Sell	36,370 -73,060	-67%	-$2.02M	0.02%	115
2019 Q2	$3.94M	Buy	109,430 +5,905	+6%	+$189K	0.11%	78
2019 Q1	$3.26M	Buy	+103,525	New	+$3.02M	0.1%	82

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Axiom Investors's CDNA Position: Q4 2019 in Review

Axiom Investors sold out of CareDx (CDNA) in Q4 2019, closing a stake of 36,370 shares — an estimated $822K sold.

Axiom Investors first reported a position in CDNA in Q1 2019 and held it in 3 quarters. The position peaked at $3.94M in Q2 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

Axiom Investors reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
Axiom Investors sold 36,370 CareDx shares in Q4 2019, an estimated $822K.
Axiom Investors first reported a position in CareDx in Q1 2019 and held it in 3 quarters.
Axiom Investors's CareDx position peaked at $3.94M in Q2 2019.
159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Axiom Investors's 13F filing for Q4 2019, filed 13 Feb 2020.